Assignee
MOLOGEN AG
DE·9 granted patents·7 pending applications·57 citations·filing 2002–2019
Top patents by PatentIndex Score
16 records- 0190US10604760B2Combination comprising immunostimulatory oligonucleotidesMOLOGEN AG·Filed 2019·Granted Mar 31, 2020·5 cites·1 claims
- 0290US10487333B2Combination comprising immunostimulatory oligonucleotidesMOLOGEN AG·Filed 2016·Granted Nov 26, 2019·7 cites·3 claims
- 0386US8017591B2Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animalsMOLOGEN AG·Filed 2006·Granted Sep 13, 2011·13 cites·11 claims
- 0485US7635468B2Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccineMOLOGEN AG·Filed 2006·Granted Dec 22, 2009·13 cites·4 claims
- 0580US10280424B2Covalently closed non-coding immunomodulatory DNA constructMOLOGEN AG·Filed 2015·Granted May 7, 2019·5 cites·5 claims
- 0679US7074772B2Design principle for the construction of expression constructs for gene therapyMOLOGEN AG·Filed 2002·Granted Jul 11, 2006·9 cites·20 claims
- 0777US10006032B2Predictive biomarker for cancer therapyMOLOGEN AG·Filed 2014·Granted Jun 26, 2018·4 cites·6 claims
- 0866US7915035B2Vaccine against oncovirus infections such as infections by feline leukosis virus of the catMOLOGEN AG·Filed 2003·Granted Mar 29, 2011·1 cites·20 claims
- 0957US2021079403A1Tlr-9 agonists for modulation of tumor microenvironmentMOLOGEN AG·Filed 2018·Application pending·0 cites
- 1053US2009004703A1Method for the Production of Suitable Dna Constructs for Specific Inhibition of Gene Expression by Rna InterferenceMOLOGEN AG·Filed 2004·Application pending·0 cites
- 1147US7795406B2Agent for treating leishmania infectionsMOLOGEN AG·Filed 2005·Granted Sep 14, 2010·0 cites·3 claims
- 1246US2020385732A1Biomarker for small cell lung cancer therapyMOLOGEN AG·Filed 2018·Application pending·0 cites
- 1344US2010303803A1Catenate for immunostimulationMOLOGEN AG·Filed 2008·Application pending·0 cites
- 1444US2009220931A1Functional in vitro immunoassayMOLOGEN AG·Filed 2006·Application pending·0 cites
- 1536US2015328308A1Means for Eliciting an Immune Response and a Method TransferMOLOGEN AG·Filed 2015·Application pending·0 cites
- 1633US2013287814A1DNA Expression ConstructMOLOGEN AG·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →